ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Generic Medicines

Contacted: U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsBills: H.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Government Accountability Office (GAO); SENATE

Bills named: S. 214 (113th), H.R. 486 (113th), S. 621 (113th), S. 504 (113th), H.R. 1285 (113th)

Medicare/Medicaid MMM

FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013

Contacted: Government Accountability Office (GAO); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC)

Bills named: S. 740 (113th), H.R. 1588 (113th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request, FY14 BudgetBills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023

Contacted: Government Accountability Office (GAO); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: H.Con.Res. 25 (113th)

Pharmacy PHA

FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs

Contacted: SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO)

Bills named: H.R. 1919 (113th), S. 504 (113th), S. 621 (113th), H.R. 1958 (113th), H.R. 1285 (113th), S. 957 (113th), S. 214 (113th), S. 959 (113th), H.Con.Res. 25 (113th), S.Res. 97 (113th), H.R. 2186 (113th)